Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase

被引:64
|
作者
Toth, Marietta [1 ]
Kun, Sandor [1 ]
Bokor, Eva [1 ]
Benltifa, Mahmoud [2 ,3 ,4 ]
Tallec, Gaylord [2 ,3 ,4 ]
Vidal, Sebastien [2 ,3 ,4 ]
Docsa, Tibor [5 ]
Gergely, Pal [6 ]
Somsak, Laszlo [1 ]
Praly, Jean-Pierre [2 ,3 ,4 ]
机构
[1] Univ Debrecen, Dept Organ Chem, H-4010 Debrecen, Hungary
[2] Univ Lyon, Inst Chim & Biochim Mol & Supramol, CNRS, Lab Chim Organ 2,UMR 5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] CPE Lyon, F-69616 Villeurbanne, France
[5] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Med Chem,Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[6] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
C-Glycosyl compounds; 1,3,4-Oxadiazoles; 1,2,4-Oxadiazoles; Glycogen phosphorylase; Inhibitors; TYPE-2; DIABETES-MELLITUS; 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES; ANTIDIABETIC AGENTS; EVOLVING EPIDEMIC; TARGETS; BINDING; MUSCLE; CYANIDES; THERAPY; AMIDES;
D O I
10.1016/j.bmc.2009.04.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of per-O-benzoylated 5-beta-D-glucopyranosyl-2-substituted-1,3,4-oxadiazoles was prepared by acylation of the corresponding 5-(beta-D-glucopyranosyl) tetrazole. As an alternative, oxidation of 2,6-anhydro-aldose benzoylhydrazones by iodobenzene I, I-diacetate afforded the same oxadiazoles. 1,3-Dipolar cycloaddition of nitrile oxides to per-O-benzoylated beta-D-glucopyranosyl cyanide gave the corresponding 5-beta-D-glucopyranosyl-3-substituted-1,2,4-oxadiazoles. The O-benzoyl protecting groups were removed by base-catalyzed transesterification. The 1,3,4-oxadiazoles were practically inefficient as inhibitors of rabbit muscle glycogen phosphorylase b while the 1,2,4-oxadiazoles displayed inhibitory activities in the micromolar range. The best inhibitors were the 5-beta-D-glucopyranosyl-3-(4-methylphenyl-and -2-naphthyl)- 1,2,4-oxadiazoles (K-i = 8.8 and 11.6 mu M, respectively). A detailed analysis of the structure-activity relationships is presented. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4773 / 4785
页数:13
相关论文
共 50 条
  • [11] Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors
    Marighetti, Federico
    Steggemann, Kerstin
    Hanl, Markus
    Wiese, Michael
    CHEMMEDCHEM, 2013, 8 (01) : 125 - 135
  • [12] Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships
    Khan, Khalid Mohammed
    Mughal, Uzma Rasool
    Khan, Mahmud Tareq Hassan
    Zia-Ullah
    Perveen, Shahnaz
    Choudhary, Muhammad Iqbal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 6027 - 6033
  • [13] STRUCTURE-ACTIVITY RELATIONSHIPS IN THYMIDINE PHOSPHORYLASE INHIBITORS - A CORRELATION USING SUBSTITUENT CONSTANTS AND REGRESSION ANALYSIS
    COATS, E
    GLAVE, WR
    HANSCH, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (05) : 913 - &
  • [14] A stereoselective synthesis of a C-glycosylated peptoid building block
    Dechantsreiter, M. A.
    Burkhart, F.
    Kessler, H.
    Tetrahedron Letters, 39 (3-4):
  • [15] A stereoselective synthesis of a C-glycosylated peptoid building block
    Dechantsreiter, MA
    Burkhart, F
    Kessler, H
    TETRAHEDRON LETTERS, 1998, 39 (3-4) : 253 - 254
  • [16] C-glycosylated pyrroles and their application in dipyrromethane and porphyrin synthesis
    Sollert, Carina
    Kocsi, Daniel
    Jane, Reuben T.
    Orthaber, Andreas
    Borbas, K. Eszter
    JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2021, 25 (7-8) : 741 - 755
  • [17] Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors
    Boehm, Kevin
    Schulze-Niemand, Eric
    Kaehne, Thilo
    Siddiqui, Elisa
    Taeger, Christian
    Ramsbeck, Daniel
    Buchholz, Mirko
    Naumann, Michael
    ARCHIV DER PHARMAZIE, 2023, 356 (07)
  • [18] Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD
    Strancar, K
    Blanot, D
    Gobec, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 343 - 348
  • [19] New indole derivatives as ACAT inhibitors: Synthesis and structure-activity relationships
    Bellemin, R
    Decerprit, J
    Festal, D
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (02) : 123 - 132
  • [20] The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
    Steinman, DH
    Curtin, ML
    Garland, RB
    Davidsen, SK
    Heyman, HR
    Holms, JH
    Albert, DH
    Magoc, TJ
    Nagy, IB
    Marcotte, PA
    Li, JL
    Morgan, DW
    Hutchins, C
    Summers, JB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2087 - 2092